Where Global Innovation
and Capital Meet
Sectors ConsumerUniversityEnergyFinancialHealthcareIndustrialITMediaServicesTelecomsTransportThe Art of CVCStartups

Page 49

Daily Deal Round Up: January 21, 2022

SoftBank Vision Fund 2 helped revenue growth technology provider 6sense close a $200m series E round at a $5.2bn valuation, cash used to acquire Gree-backed sales software developer Saleswhale.

Jan 21, 2022

Daily Deal Round Up: January 20, 2022

Mental health app developer Lyra Health raised $235m from investors including Salesforce while blockchain development software provider Secret Network launched a $225m ecosystem fund.

Jan 20, 2022

SoftBank sinks funding into Shoplazza and Big Health

Vision Fund 2 invested in e-commerce software provider Shoplazza and digital therapeutics developer Big Health as part of what is becoming a busy January.

Jan 20, 2022

Wheel rolls out $150m series C

Salesforce was among the investors that backed the virtual health service’s latest round, helping it take its funding to $216m altogether.

Jan 20, 2022

Powerlist Q&A – Rob Coppedge, Echo Health Ventures

Q&A with Rob Coppedge, CEO, Echo Health Ventures

Jan 20, 2022

Daily Deal Round Up: January 19, 2022

Volkswagen Group invested a nine-figure amount in 24M Technologies while SoftBank participated in a $100m series C round for Pixis.

Jan 19, 2022

Verana Health mines $150m

Johnson & Johnson, Novo and Alphabet all invested in the clinical data platform developer’s latest round, as big data analytics moves further into healthcare.

Jan 19, 2022

Daily Deal Round Up: January 18, 2022

Bank of Montreal provided debt and equity financing for industrial product marketplace Inxeption, which raised $275m, while smart home product maker Orvibo received $158m.

Jan 18, 2022

Torres joins Altaris as MD

Rafael Torres had spent 14 years leading the healthcare investing teams at GE Equity and GE Ventures up to 2015.

Jan 18, 2022

Analysis: Freenome cracks $290m

Cancer diagnostics tech developer Freenome cashed in an additional $290m from returning investor Roche, which will support it as it looks to expand its products to additional cancers.

Jan 17, 2022
© 2024 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here